Literature DB >> 10721822

Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin.

H Törmä1, T Karlsson, G Michaëlsson, O Rollman, A Vahlquist.   

Abstract

Retinoic acid, vitamin D3 and triiodothyronine regulate keratinocyte proliferation and differentiation--processes that are disturbed in psoriatic skin--via binding to nuclear receptors for retinoic acid (RAR-alpha,-gamma), vitamin D3 (VDR), thyroid hormone (TR-alpha,-beta) plus the common heterodimer partners, the 9-cis-retinoic acid receptors (RXR-alpha,-beta). By using a new quantitative real-time polymerase chain reaction assay, the expression of these receptors and three housekeeping genes (cyclophilin, GAPDH and beta-actin) was studied in psoriatic skin. The expression of housekeeping genes was consistently 2.7-4.3 times higher in lesional than in non-lesional skin. When the beta-actin expression was used to normalize the receptor mRNA values, the RARalpha, RXRalpha and TRalpha transcripts were found to be 58-75% lower in lesional vs. non-lesional skin and the RXRalpha:RARgamma ratio was reduced from 3.2 to 1.5. Topical treatment for 4 days with 0.025% all-trans-retinoic acid or calcipotriol under occlusion did not normalize the altered mRNA expression of RARs, RXR and VDR in lesional skin. The results suggest that retinoid and thyroid hormone signalling is abnormal in lesional psoriatic skin, but how this relates to the pathogenesis of the disease is still unclear.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10721822     DOI: 10.1080/000155500750012405

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

1.  Thyroid hormone action on skin.

Authors:  Joshua D Safer
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 2.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

3.  Topical L-thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?

Authors:  Ralf Paus; Yuval Ramot; Robert S Kirsner; Marjana Tomic-Canic
Journal:  Exp Dermatol       Date:  2020-08-28       Impact factor: 3.960

Review 4.  Skin disorders and thyroid diseases.

Authors:  H Niepomniszcze; R H Amad
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

5.  Expression of beta defensins in ocular surface tissue of experimentally developed allergic conjunctivitis mouse model.

Authors:  Ai Ikeda; Yoko Nakanishi; Tohru Sakimoto; Jun Shoji; Mitsuru Sawa; Norimichi Nemoto
Journal:  Jpn J Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 2.447

6.  Expression patterns of TRα and CRABPII genes in Chinese cashmere goat skin during prenatal development.

Authors:  Tao Zhong; Wei Zhao; Zhongqiang Zhou; Li Li; Linjie Wang; Hua Li; Hongping Zhang
Journal:  J Anim Sci Technol       Date:  2015-08-20

7.  Comparative study of Danshen and Siwu decoction based on the molecular structures of the components and predicted targets.

Authors:  Yang Li; Li Qiao; Cong Chen; Zhenguo Wang; Xianjun Fu
Journal:  BMC Complement Med Ther       Date:  2021-01-22

Review 8.  Etiological Association Between Psoriasis and Thyroid Diseases.

Authors:  Srilatha Eapi; Rupak Chowdhury; Odunayo S Lawal; Nimisha Mathur; Bilal Haider Malik
Journal:  Cureus       Date:  2021-01-12

9.  Thyroid hormone and wound healing.

Authors:  Joshua D Safer
Journal:  J Thyroid Res       Date:  2013-03-20

10.  Selection and validation of endogenous reference genes using a high throughput approach.

Authors:  Ping Jin; Yingdong Zhao; Yvonne Ngalame; Monica C Panelli; Dirk Nagorsen; Vladia Monsurró; Kina Smith; Nan Hu; Hua Su; Phil R Taylor; Francesco M Marincola; Ena Wang
Journal:  BMC Genomics       Date:  2004-08-13       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.